Aclaris Therapeutics, Inc. (ACRS)

USD 3.08

(-5.52%)

Total Debt Summary of Aclaris Therapeutics, Inc.

  • Aclaris Therapeutics, Inc.'s latest annual total debt in 2023 was 426 Thousand USD , down -37.72% from previous year.
  • Aclaris Therapeutics, Inc.'s latest quarterly total debt in 2024 Q2 was 2.81 Million USD , down -18.94% from previous quarter.
  • Aclaris Therapeutics, Inc. reported annual total debt of 684 Thousand USD in 2022, down -1.3% from previous year.
  • Aclaris Therapeutics, Inc. reported annual total debt of 693 Thousand USD in 2021, down -93.84% from previous year.
  • Aclaris Therapeutics, Inc. reported quarterly total debt of 2.81 Million USD for 2024 Q2, down -18.94% from previous quarter.
  • Aclaris Therapeutics, Inc. reported quarterly total debt of 310 Thousand USD for 2023 Q3, down -32.31% from previous quarter.

Annual Total Debt Chart of Aclaris Therapeutics, Inc. (2023 - 2013)

Historical Annual Total Debt of Aclaris Therapeutics, Inc. (2023 - 2013)

Year Total Debt Total Debt Growth
2023 426 Thousand USD -37.72%
2022 684 Thousand USD -1.3%
2021 693 Thousand USD -93.84%
2020 11.25 Million USD 1667.03%
2019 637 Thousand USD -97.91%
2018 30.51 Million USD 21389.44%
2017 142 Thousand USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%

Peer Total Debt Comparison of Aclaris Therapeutics, Inc.

Name Total Debt Total Debt Difference
Bionano Genomics, Inc. 87.94 Million USD 99.516%
Prenetics Global Limited 2.36 Million USD 82.021%
Star Equity Holdings, Inc. 3.6 Million USD 88.196%
CareDx, Inc 34.22 Million USD 98.755%
Exact Sciences Corporation 2.55 Billion USD 99.983%
Exagen Inc. 23.72 Million USD 98.204%
Inotiv, Inc. 417.64 Million USD 99.898%
Guardant Health, Inc. 1.35 Billion USD 99.969%
Biodesix, Inc. 60.69 Million USD 99.298%
BioNexus Gene Lab Corp. 133.39 Thousand USD -219.352%
Precipio, Inc. 1.11 Million USD 61.828%
iSpecimen Inc. 196.24 Thousand USD -117.077%
Natera, Inc. 441.99 Million USD 99.904%
Aspira Women's Health Inc. 2.26 Million USD 81.2%
Standard BioTools Inc. 98.21 Million USD 99.566%
23andMe Holding Co. 76.51 Million USD 99.443%
Castle Biosciences, Inc. 15.31 Million USD 97.218%
Personalis, Inc. 48.96 Million USD 99.13%
Applied DNA Sciences, Inc. 1.23 Million USD 65.583%
OpGen, Inc. 13.04 Million USD 96.734%
T2 Biosystems, Inc. 49.49 Million USD 99.139%
Myriad Genetics, Inc. 145 Million USD 99.706%
ICON Public Limited Company 3.93 Billion USD 99.989%
NeoGenomics, Inc. 611.67 Million USD 99.93%
Star Equity Holdings, Inc. 3.6 Million USD 88.196%
IDEXX Laboratories, Inc. 947.88 Million USD 99.955%
RadNet, Inc. 1.49 Billion USD 99.971%
MDxHealth SA 41.26 Million USD 98.968%
Psychemedics Corporation 2.29 Million USD 81.462%
Illumina, Inc. 2.26 Billion USD 99.981%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 94.06 Million USD 99.547%
DarioHealth Corp. 29.54 Million USD 98.558%
Fulgent Genetics, Inc. 14.9 Million USD 97.142%
Sera Prognostics, Inc. 1.85 Million USD 77.072%
ENDRA Life Sciences Inc. 394.4 Thousand USD -8.011%
OPKO Health, Inc. 326.56 Million USD 99.87%
Medpace Holdings, Inc. 142.12 Million USD 99.7%
Neogen Corporation 906.23 Million USD 99.953%
Intelligent Bio Solutions Inc. 871.44 Thousand USD 51.115%
Prenetics Global Limited 2.36 Million USD 82.021%
Mainz Biomed B.V. 7.42 Million USD 94.259%
bioAffinity Technologies, Inc. 1.57 Million USD 73.015%
Trinity Biotech plc 67.42 Million USD 99.368%
Neuronetics, Inc. 62.47 Million USD 99.318%
Sotera Health Company 2.32 Billion USD 99.982%
bioAffinity Technologies, Inc. 1.57 Million USD 73.015%